| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $88.7B | $91.1B | $91.0B | $100.3B | $97.3B | $24.9B | $20.6B | $19.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $7.9B | $8.5B | $9.1B | $13.1B | $12.8B | $2.0B | $2.1B | $2.0B |
| Net Income | $5.6B | $5.8B | $6.7B | $11.5B | $12.9B | $-3.3B | $-0.1B | $0.5B |
| EPS (Basic) | $6.56 | $6.76 | $7.81 | $13.26 | $14.75 | $-3.84 | $-0.12 | $0.52 |
| EPS (Diluted) | $6.56 | $6.75 | $7.80 | $13.20 | $14.68 | $-3.84 | $-0.12 | $0.52 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $73.1B | $70.1B | $70.9B | $71.1B | $69.4B | $62.4B | $57.9B | $50.0B |
| Current Assets | $19.0B | $19.3B | $19.4B | $22.2B | $24.9B | $20.2B | $17.1B | $16.2B |
| Cash & Equivalents | $5.9B | $6.1B | $3.2B | $5.6B | $10.3B | $5.9B | $5.2B | $4.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $15.6B | $16.4B | $17.7B | $18.1B | $17.6B | $17.0B | $15.4B | $14.1B |
| Stockholders' Equity | $16.2B | $16.7B | $17.3B | $19.8B | $14.3B | $0.7B | $3.3B | $3.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.4B | $10.1B | $10.2B | $14.1B | $15.0B | $10.5B | $8.6B | $12.7B |
| Investing Cash Flow | $-4.7B | $-0.2B | $-7.1B | $-7.5B | $-3.8B | $-5.3B | $-6.1B | $-6.3B |
| Capital Expenditures | $3.7B | $3.9B | $5.2B | $4.8B | $4.2B | $5.4B | $6.4B | $6.3B |
| Financing Cash Flow | $-4.1B | $-6.8B | $-5.5B | $-11.2B | $-6.8B | $-4.5B | $-1.7B | $-5.7B |